Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
GRI BIO, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Quarterly results
Docs: "GRI Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update Rapidly advancing clinical pipeline across multiple high-value inflammatory, fibrotic and autoimmune diseases"
02/24/2023 8-K Quarterly results
Docs: "Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial Results"
07/28/2022 8-K Quarterly results
Docs: "Vallon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update"
05/09/2022 8-K Quarterly results
Docs: "Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update"
02/14/2022 8-K Quarterly results
Docs: "Vallon Pharmaceuticals Reports Fiscal Year 2021 Financial Results and Provides Business Update - Topline data for pivotal abuse study of the Company’s lead investigational program ADAIR expected this quarter"
11/12/2021 8-K Quarterly results
Docs: "Vallon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update - Ongoing pivotal intranasal abuse study of lead program, ADAIR, advancing toward completion of patient enrollment and treatment in Q1 2022"
08/10/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy